nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—breast cancer	0.409	0.569	CbGaD
Amifostine—ALPL—breast cancer	0.31	0.431	CbGaD
Amifostine—ALPPL2—arm—breast cancer	0.0119	0.155	CbGeAlD
Amifostine—ALPL—mammary gland—breast cancer	0.00589	0.0767	CbGeAlD
Amifostine—ENPP1—mammary gland—breast cancer	0.00541	0.0704	CbGeAlD
Amifostine—ALPPL2—embryo—breast cancer	0.00356	0.0463	CbGeAlD
Amifostine—ALPL—endometrium—breast cancer	0.00294	0.0383	CbGeAlD
Amifostine—ALPPL2—epithelium—breast cancer	0.0029	0.0378	CbGeAlD
Amifostine—ENPP1—skin of body—breast cancer	0.00287	0.0373	CbGeAlD
Amifostine—ALPPL2—skin of body—breast cancer	0.00276	0.0359	CbGeAlD
Amifostine—ALPL—adipose tissue—breast cancer	0.00265	0.0345	CbGeAlD
Amifostine—ALPPL2—endometrium—breast cancer	0.0026	0.0339	CbGeAlD
Amifostine—ENPP1—uterus—breast cancer	0.00249	0.0324	CbGeAlD
Amifostine—ENPP1—adipose tissue—breast cancer	0.00243	0.0317	CbGeAlD
Amifostine—ALPPL2—uterus—breast cancer	0.0024	0.0312	CbGeAlD
Amifostine—ALPL—adrenal gland—breast cancer	0.00238	0.031	CbGeAlD
Amifostine—ALPPL2—adipose tissue—breast cancer	0.00235	0.0305	CbGeAlD
Amifostine—ENPP1—female reproductive system—breast cancer	0.00224	0.0291	CbGeAlD
Amifostine—ALPL—female gonad—breast cancer	0.00222	0.0289	CbGeAlD
Amifostine—ENPP1—adrenal gland—breast cancer	0.00218	0.0284	CbGeAlD
Amifostine—ALPPL2—female reproductive system—breast cancer	0.00216	0.0281	CbGeAlD
Amifostine—ALPPL2—bone marrow—breast cancer	0.00204	0.0265	CbGeAlD
Amifostine—ENPP1—female gonad—breast cancer	0.00204	0.0265	CbGeAlD
Amifostine—ALPPL2—female gonad—breast cancer	0.00196	0.0255	CbGeAlD
Amifostine—ENPP1—endocrine gland—breast cancer	0.00189	0.0246	CbGeAlD
Amifostine—ALPPL2—endocrine gland—breast cancer	0.00183	0.0238	CbGeAlD
Amifostine—ALPL—lymph node—breast cancer	0.00143	0.0186	CbGeAlD
Amifostine—ENPP1—Betamethasone—Fluoxymesterone—breast cancer	0.00134	0.5	CbGdCrCtD
Amifostine—ENPP1—Dexamethasone—Fluoxymesterone—breast cancer	0.00134	0.5	CbGdCrCtD
Amifostine—ENPP1—lymph node—breast cancer	0.00131	0.017	CbGeAlD
Amifostine—ENPP1—Endochondral Ossification—IGF1—breast cancer	0.000408	0.00468	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—RAF1—breast cancer	0.000401	0.00461	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—RELA—breast cancer	0.000399	0.00459	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—STAT5A—breast cancer	0.000392	0.0045	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—SLC2A1—breast cancer	0.000376	0.00432	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CASP3—breast cancer	0.00036	0.00414	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—JUN—breast cancer	0.00035	0.00402	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—EGR1—breast cancer	0.000349	0.00401	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—MMP9—breast cancer	0.000349	0.00401	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—SPP1—breast cancer	0.000343	0.00394	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MMP9—breast cancer	0.000341	0.00391	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAPK8—breast cancer	0.000331	0.0038	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—SRC—breast cancer	0.000314	0.0036	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—VEGFA—breast cancer	0.000313	0.0036	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—STAT3—breast cancer	0.000303	0.00348	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—MMP9—breast cancer	0.000297	0.00341	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—IGF1R—breast cancer	0.000295	0.00339	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAPK3—breast cancer	0.000289	0.00332	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—TGFB1—breast cancer	0.000288	0.0033	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—NFKBIA—breast cancer	0.000283	0.00325	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—EGFR—breast cancer	0.000275	0.00316	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—APC—breast cancer	0.000274	0.00314	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—VEGFA—breast cancer	0.000266	0.00306	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—breast cancer	0.000265	0.00304	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—FOS—breast cancer	0.000261	0.003	CbGpPWpGaD
Amifostine—ENPP1—Disease—MFGE8—breast cancer	0.000248	0.00284	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—TGFB1—breast cancer	0.000245	0.00281	CbGpPWpGaD
Amifostine—ENPP1—Disease—CHST9—breast cancer	0.000217	0.00249	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—RAF1—breast cancer	0.000215	0.00247	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CG—breast cancer	0.000214	0.00246	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—RELA—breast cancer	0.000214	0.00246	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MTOR—breast cancer	0.00021	0.00241	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SYNJ2—breast cancer	0.000208	0.00238	CbGpPWpGaD
Amifostine—ENPP1—Disease—CCDC88C—breast cancer	0.000205	0.00236	CbGpPWpGaD
Amifostine—ENPP1—Disease—LGR6—breast cancer	0.000205	0.00236	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—FOS—breast cancer	0.000204	0.00234	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—AKT1—breast cancer	0.0002	0.0023	CbGpPWpGaD
Amifostine—ENPP1—Disease—SFRP1—breast cancer	0.000196	0.00225	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—AKT2—breast cancer	0.000196	0.00225	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—AKT1—breast cancer	0.000195	0.00224	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CASP3—breast cancer	0.000193	0.00222	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NDUFS3—breast cancer	0.000193	0.00221	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CD—breast cancer	0.000188	0.00216	CbGpPWpGaD
Amifostine—ENPP1—Disease—SHMT1—breast cancer	0.000188	0.00216	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—JUN—breast cancer	0.000187	0.00215	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CTNNB1—breast cancer	0.000186	0.00214	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CHST9—breast cancer	0.000181	0.00208	CbGpPWpGaD
Amifostine—ENPP1—Disease—SLC2A5—breast cancer	0.000181	0.00207	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MAPK8—breast cancer	0.000177	0.00204	CbGpPWpGaD
Amifostine—ENPP1—Disease—CUL5—breast cancer	0.000175	0.002	CbGpPWpGaD
Amifostine—ENPP1—Disease—HEYL—breast cancer	0.000175	0.002	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—COX11—breast cancer	0.000172	0.00197	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—AKT1—breast cancer	0.00017	0.00195	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—SRC—breast cancer	0.000168	0.00193	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—RAF1—breast cancer	0.000168	0.00193	CbGpPWpGaD
Amifostine—ENPP1—Disease—RSPO3—breast cancer	0.000164	0.00188	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CB—breast cancer	0.000164	0.00188	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MTOR—breast cancer	0.000164	0.00188	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—STAT3—breast cancer	0.000162	0.00186	CbGpPWpGaD
Amifostine—ENPP1—Disease—WNT10B—breast cancer	0.00016	0.00183	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SHMT1—breast cancer	0.000157	0.00181	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CDA—breast cancer	0.000157	0.00181	CbGpPWpGaD
Amifostine—ENPP1—Disease—GPI—breast cancer	0.000156	0.00179	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MAPK3—breast cancer	0.000155	0.00178	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLCO1B1—breast cancer	0.000151	0.00174	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC2A5—breast cancer	0.000151	0.00174	CbGpPWpGaD
Amifostine—ENPP1—Disease—DLL4—breast cancer	0.000148	0.0017	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—JUN—breast cancer	0.000147	0.00168	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—APRT—breast cancer	0.000146	0.00168	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PTEN—breast cancer	0.000142	0.00163	CbGpPWpGaD
Amifostine—ENPP1—Disease—LDHB—breast cancer	0.00014	0.0016	CbGpPWpGaD
Amifostine—ENPP1—Disease—RPL31—breast cancer	0.00014	0.0016	CbGpPWpGaD
Amifostine—ENPP1—Disease—SFRP2—breast cancer	0.00014	0.0016	CbGpPWpGaD
Amifostine—ENPP1—Disease—HPSE—breast cancer	0.00014	0.0016	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MAPK8—breast cancer	0.000139	0.00159	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ESRRA—breast cancer	0.000137	0.00158	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ANGPTL4—breast cancer	0.000137	0.00158	CbGpPWpGaD
Amifostine—ENPP1—Disease—VCP—breast cancer	0.000132	0.00152	CbGpPWpGaD
Amifostine—ENPP1—Disease—ABCC1—breast cancer	0.000132	0.00152	CbGpPWpGaD
Amifostine—ENPP1—Disease—HMMR—breast cancer	0.000132	0.00152	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HADHB—breast cancer	0.00013	0.0015	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GPI—breast cancer	0.00013	0.0015	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFBI—breast cancer	0.00013	0.00149	CbGpPWpGaD
Amifostine—ENPP1—Disease—RPS4X—breast cancer	0.00013	0.00149	CbGpPWpGaD
Amifostine—ENPP1—Disease—ELL—breast cancer	0.000124	0.00143	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ALDH1A1—breast cancer	0.000124	0.00143	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ALDH7A1—breast cancer	0.000124	0.00143	CbGpPWpGaD
Amifostine—Urticaria—Vinorelbine—breast cancer	0.000124	0.00108	CcSEcCtD
Amifostine—Bradycardia—Capecitabine—breast cancer	0.000124	0.00107	CcSEcCtD
Amifostine—Body temperature increased—Vinorelbine—breast cancer	0.000124	0.00107	CcSEcCtD
Amifostine—Pruritus—Goserelin—breast cancer	0.000124	0.00107	CcSEcCtD
Amifostine—Anaphylactic shock—Fluorouracil—breast cancer	0.000124	0.00107	CcSEcCtD
Amifostine—Feeling abnormal—Thiotepa—breast cancer	0.000123	0.00107	CcSEcCtD
Amifostine—Nausea—Chlorambucil—breast cancer	0.000122	0.00106	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—MAPK3—breast cancer	0.000121	0.00139	CbGpPWpGaD
Amifostine—Dizziness—Tamoxifen—breast cancer	0.000121	0.00105	CcSEcCtD
Amifostine—Tachycardia—Fluorouracil—breast cancer	0.000121	0.00105	CcSEcCtD
Amifostine—Hypotension—Mitoxantrone—breast cancer	0.000121	0.00105	CcSEcCtD
Amifostine—Hypotension—Irinotecan—breast cancer	0.000121	0.00105	CcSEcCtD
Amifostine—Dermatitis exfoliative—Doxorubicin—breast cancer	0.00012	0.00104	CcSEcCtD
Amifostine—Vomiting—Vinblastine—breast cancer	0.00012	0.00104	CcSEcCtD
Amifostine—Ill-defined disorder—Paclitaxel—breast cancer	0.00012	0.00104	CcSEcCtD
Amifostine—ENPP1—Metabolism—UMPS—breast cancer	0.000119	0.00137	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NME1—breast cancer	0.000119	0.00137	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—FHL2—breast cancer	0.000119	0.00137	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ADSL—breast cancer	0.000119	0.00137	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PHGDH—breast cancer	0.000119	0.00137	CbGpPWpGaD
Amifostine—Erythema multiforme—Docetaxel—breast cancer	0.000119	0.00103	CcSEcCtD
Amifostine—Urticaria—Thiotepa—breast cancer	0.000119	0.00103	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—HRAS—breast cancer	0.000118	0.00136	CbGpPWpGaD
Amifostine—Body temperature increased—Thiotepa—breast cancer	0.000118	0.00103	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Methotrexate—breast cancer	0.000118	0.00102	CcSEcCtD
Amifostine—Hypotension—Gemcitabine—breast cancer	0.000117	0.00102	CcSEcCtD
Amifostine—Anaphylactoid reaction—Doxorubicin—breast cancer	0.000117	0.00102	CcSEcCtD
Amifostine—ENPP1—Metabolism—HPSE—breast cancer	0.000117	0.00134	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—BRIP1—breast cancer	0.000117	0.00134	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—LDHB—breast cancer	0.000117	0.00134	CbGpPWpGaD
Amifostine—ENPP1—Disease—HEY2—breast cancer	0.000116	0.00134	CbGpPWpGaD
Amifostine—Flushing—Docetaxel—breast cancer	0.000116	0.00101	CcSEcCtD
Amifostine—Cardiac arrest—Epirubicin—breast cancer	0.000116	0.00101	CcSEcCtD
Amifostine—Vomiting—Tamoxifen—breast cancer	0.000116	0.00101	CcSEcCtD
Amifostine—Malaise—Paclitaxel—breast cancer	0.000116	0.00101	CcSEcCtD
Amifostine—Syncope—Paclitaxel—breast cancer	0.000116	0.001	CcSEcCtD
Amifostine—Dizziness—Goserelin—breast cancer	0.000115	0.001	CcSEcCtD
Amifostine—Hypotension—Fluorouracil—breast cancer	0.000115	0.001	CcSEcCtD
Amifostine—Rash—Tamoxifen—breast cancer	0.000115	0.001	CcSEcCtD
Amifostine—Hypersensitivity—Vinorelbine—breast cancer	0.000115	0.001	CcSEcCtD
Amifostine—Dermatitis—Tamoxifen—breast cancer	0.000115	0.001	CcSEcCtD
Amifostine—ENPP1—Disease—RPS6KB2—breast cancer	0.000115	0.00132	CbGpPWpGaD
Amifostine—Dyspnoea—Irinotecan—breast cancer	0.000115	0.000999	CcSEcCtD
Amifostine—Dyspnoea—Mitoxantrone—breast cancer	0.000115	0.000999	CcSEcCtD
Amifostine—Erythema multiforme—Capecitabine—breast cancer	0.000115	0.000998	CcSEcCtD
Amifostine—Somnolence—Irinotecan—breast cancer	0.000115	0.000996	CcSEcCtD
Amifostine—Somnolence—Mitoxantrone—breast cancer	0.000115	0.000996	CcSEcCtD
Amifostine—Vomiting—Melphalan—breast cancer	0.000114	0.000989	CcSEcCtD
Amifostine—ENPP1—Disease—IDH1—breast cancer	0.000114	0.00131	CbGpPWpGaD
Amifostine—Loss of consciousness—Paclitaxel—breast cancer	0.000113	0.000984	CcSEcCtD
Amifostine—Rash—Melphalan—breast cancer	0.000113	0.00098	CcSEcCtD
Amifostine—Flushing—Capecitabine—breast cancer	0.000113	0.000979	CcSEcCtD
Amifostine—Dermatitis—Melphalan—breast cancer	0.000113	0.000979	CcSEcCtD
Amifostine—Chills—Docetaxel—breast cancer	0.000113	0.000978	CcSEcCtD
Amifostine—Arrhythmia—Docetaxel—breast cancer	0.000112	0.000974	CcSEcCtD
Amifostine—Dyspnoea—Gemcitabine—breast cancer	0.000112	0.000973	CcSEcCtD
Amifostine—Nausea—Vinblastine—breast cancer	0.000112	0.000971	CcSEcCtD
Amifostine—Somnolence—Gemcitabine—breast cancer	0.000112	0.00097	CcSEcCtD
Amifostine—Convulsion—Paclitaxel—breast cancer	0.000112	0.00097	CcSEcCtD
Amifostine—Hypertension—Paclitaxel—breast cancer	0.000111	0.000967	CcSEcCtD
Amifostine—Vomiting—Goserelin—breast cancer	0.000111	0.000964	CcSEcCtD
Amifostine—ENPP1—Metabolism—HMMR—breast cancer	0.000111	0.00127	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ABCC1—breast cancer	0.000111	0.00127	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTA3—breast cancer	0.000111	0.00127	CbGpPWpGaD
Amifostine—Pruritus—Vinorelbine—breast cancer	0.000111	0.000961	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Epirubicin—breast cancer	0.00011	0.000957	CcSEcCtD
Amifostine—Dyspnoea—Fluorouracil—breast cancer	0.00011	0.000957	CcSEcCtD
Amifostine—Rash—Goserelin—breast cancer	0.00011	0.000956	CcSEcCtD
Amifostine—Hypersensitivity—Thiotepa—breast cancer	0.00011	0.000956	CcSEcCtD
Amifostine—Dermatitis—Goserelin—breast cancer	0.00011	0.000955	CcSEcCtD
Amifostine—Somnolence—Fluorouracil—breast cancer	0.00011	0.000954	CcSEcCtD
Amifostine—Chest pain—Paclitaxel—breast cancer	0.00011	0.000953	CcSEcCtD
Amifostine—Chills—Capecitabine—breast cancer	0.000109	0.000947	CcSEcCtD
Amifostine—ENPP1—Disease—TLE3—breast cancer	0.000109	0.00125	CbGpPWpGaD
Amifostine—Nausea—Tamoxifen—breast cancer	0.000109	0.000943	CcSEcCtD
Amifostine—Arrhythmia—Capecitabine—breast cancer	0.000109	0.000943	CcSEcCtD
Amifostine—Discomfort—Paclitaxel—breast cancer	0.000108	0.000942	CcSEcCtD
Amifostine—ENPP1—Disease—HEY1—breast cancer	0.000108	0.00124	CbGpPWpGaD
Amifostine—Cardiac arrest—Doxorubicin—breast cancer	0.000108	0.000935	CcSEcCtD
Amifostine—ENPP1—Metabolism—PPARGC1B—breast cancer	0.000107	0.00123	CbGpPWpGaD
Amifostine—Nausea—Melphalan—breast cancer	0.000106	0.000924	CcSEcCtD
Amifostine—Feeling abnormal—Irinotecan—breast cancer	0.000106	0.000923	CcSEcCtD
Amifostine—Feeling abnormal—Mitoxantrone—breast cancer	0.000106	0.000923	CcSEcCtD
Amifostine—ENPP1—Disease—RPL23A—breast cancer	0.000106	0.00121	CbGpPWpGaD
Amifostine—ENPP1—Disease—DLL1—breast cancer	0.000106	0.00121	CbGpPWpGaD
Amifostine—Pruritus—Thiotepa—breast cancer	0.000106	0.000918	CcSEcCtD
Amifostine—Anaphylactic shock—Paclitaxel—breast cancer	0.000105	0.000914	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—AKT1—breast cancer	0.000105	0.0012	CbGpPWpGaD
Amifostine—ENPP1—Disease—HIST1H2BC—breast cancer	0.000104	0.00119	CbGpPWpGaD
Amifostine—ENPP1—Disease—MAP2K7—breast cancer	0.000104	0.00119	CbGpPWpGaD
Amifostine—ENPP1—Disease—HIST1H2BK—breast cancer	0.000104	0.00119	CbGpPWpGaD
Amifostine—Nausea—Goserelin—breast cancer	0.000104	0.000901	CcSEcCtD
Amifostine—Feeling abnormal—Gemcitabine—breast cancer	0.000104	0.000899	CcSEcCtD
Amifostine—Shock—Paclitaxel—breast cancer	0.000103	0.000899	CcSEcCtD
Amifostine—Dizziness—Vinorelbine—breast cancer	0.000103	0.000898	CcSEcCtD
Amifostine—Tachycardia—Paclitaxel—breast cancer	0.000103	0.000892	CcSEcCtD
Amifostine—Urticaria—Mitoxantrone—breast cancer	0.000102	0.00089	CcSEcCtD
Amifostine—Body temperature increased—Mitoxantrone—breast cancer	0.000102	0.000886	CcSEcCtD
Amifostine—Body temperature increased—Irinotecan—breast cancer	0.000102	0.000886	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000102	0.000886	CcSEcCtD
Amifostine—Feeling abnormal—Fluorouracil—breast cancer	0.000102	0.000884	CcSEcCtD
Amifostine—ENPP1—Metabolism—CA9—breast cancer	0.000101	0.00116	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTA4—breast cancer	0.000101	0.00116	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CA—breast cancer	0.0001	0.00115	CbGpPWpGaD
Amifostine—Stevens-Johnson syndrome—Methotrexate—breast cancer	9.99e-05	0.000868	CcSEcCtD
Amifostine—Vomiting—Vinorelbine—breast cancer	9.94e-05	0.000864	CcSEcCtD
Amifostine—Body temperature increased—Gemcitabine—breast cancer	9.93e-05	0.000863	CcSEcCtD
Amifostine—Renal failure—Methotrexate—breast cancer	9.91e-05	0.00086	CcSEcCtD
Amifostine—Dizziness—Thiotepa—breast cancer	9.88e-05	0.000858	CcSEcCtD
Amifostine—ENPP1—Metabolism—GPX2—breast cancer	9.88e-05	0.00113	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTA2—breast cancer	9.88e-05	0.00113	CbGpPWpGaD
Amifostine—ENPP1—Disease—RPS7—breast cancer	9.86e-05	0.00113	CbGpPWpGaD
Amifostine—ENPP1—Disease—RPS8—breast cancer	9.86e-05	0.00113	CbGpPWpGaD
Amifostine—Rash—Vinorelbine—breast cancer	9.86e-05	0.000856	CcSEcCtD
Amifostine—Dermatitis—Vinorelbine—breast cancer	9.85e-05	0.000856	CcSEcCtD
Amifostine—Hypotension—Paclitaxel—breast cancer	9.83e-05	0.000854	CcSEcCtD
Amifostine—Ill-defined disorder—Capecitabine—breast cancer	9.81e-05	0.000852	CcSEcCtD
Amifostine—Urticaria—Fluorouracil—breast cancer	9.81e-05	0.000852	CcSEcCtD
Amifostine—Syncope—Docetaxel—breast cancer	9.8e-05	0.000851	CcSEcCtD
Amifostine—ENPP1—Disease—DKK1—breast cancer	9.79e-05	0.00112	CbGpPWpGaD
Amifostine—Body temperature increased—Fluorouracil—breast cancer	9.77e-05	0.000848	CcSEcCtD
Amifostine—ENPP1—Metabolism—GPX4—breast cancer	9.75e-05	0.00112	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SULT1A1—breast cancer	9.75e-05	0.00112	CbGpPWpGaD
Amifostine—ENPP1—Disease—ALDOA—breast cancer	9.71e-05	0.00111	CbGpPWpGaD
Amifostine—Loss of consciousness—Docetaxel—breast cancer	9.6e-05	0.000834	CcSEcCtD
Amifostine—ENPP1—Disease—JAG2—breast cancer	9.57e-05	0.0011	CbGpPWpGaD
Amifostine—Malaise—Capecitabine—breast cancer	9.54e-05	0.000828	CcSEcCtD
Amifostine—ENPP1—Metabolism—IDH1—breast cancer	9.53e-05	0.00109	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTA1—breast cancer	9.53e-05	0.00109	CbGpPWpGaD
Amifostine—Hypersensitivity—Irinotecan—breast cancer	9.5e-05	0.000825	CcSEcCtD
Amifostine—Hypersensitivity—Mitoxantrone—breast cancer	9.5e-05	0.000825	CcSEcCtD
Amifostine—Vomiting—Thiotepa—breast cancer	9.5e-05	0.000825	CcSEcCtD
Amifostine—Syncope—Capecitabine—breast cancer	9.49e-05	0.000824	CcSEcCtD
Amifostine—Convulsion—Docetaxel—breast cancer	9.47e-05	0.000822	CcSEcCtD
Amifostine—Hypertension—Docetaxel—breast cancer	9.43e-05	0.000819	CcSEcCtD
Amifostine—ENPP1—Disease—WNT1—breast cancer	9.43e-05	0.00108	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NAT2—breast cancer	9.42e-05	0.00108	CbGpPWpGaD
Amifostine—Rash—Thiotepa—breast cancer	9.42e-05	0.000818	CcSEcCtD
Amifostine—Dermatitis—Thiotepa—breast cancer	9.41e-05	0.000817	CcSEcCtD
Amifostine—Dyspnoea—Paclitaxel—breast cancer	9.38e-05	0.000815	CcSEcCtD
Amifostine—ENPP1—Disease—SLC2A2—breast cancer	9.36e-05	0.00107	CbGpPWpGaD
Amifostine—Somnolence—Paclitaxel—breast cancer	9.35e-05	0.000812	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Epirubicin—breast cancer	9.35e-05	0.000812	CcSEcCtD
Amifostine—Chest pain—Docetaxel—breast cancer	9.3e-05	0.000808	CcSEcCtD
Amifostine—Loss of consciousness—Capecitabine—breast cancer	9.3e-05	0.000807	CcSEcCtD
Amifostine—Nausea—Vinorelbine—breast cancer	9.29e-05	0.000807	CcSEcCtD
Amifostine—Renal failure—Epirubicin—breast cancer	9.27e-05	0.000805	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—HRAS—breast cancer	9.25e-05	0.00106	CbGpPWpGaD
Amifostine—ENPP1—Disease—MTR—breast cancer	9.17e-05	0.00105	CbGpPWpGaD
Amifostine—Hypertension—Capecitabine—breast cancer	9.13e-05	0.000793	CcSEcCtD
Amifostine—Hypersensitivity—Fluorouracil—breast cancer	9.1e-05	0.000791	CcSEcCtD
Amifostine—Chest pain—Capecitabine—breast cancer	9.01e-05	0.000782	CcSEcCtD
Amifostine—Anaphylactic shock—Docetaxel—breast cancer	8.92e-05	0.000774	CcSEcCtD
Amifostine—Discomfort—Capecitabine—breast cancer	8.9e-05	0.000773	CcSEcCtD
Amifostine—Pruritus—Gemcitabine—breast cancer	8.89e-05	0.000772	CcSEcCtD
Amifostine—Nausea—Thiotepa—breast cancer	8.87e-05	0.000771	CcSEcCtD
Amifostine—Shock—Docetaxel—breast cancer	8.77e-05	0.000762	CcSEcCtD
Amifostine—Pruritus—Fluorouracil—breast cancer	8.74e-05	0.000759	CcSEcCtD
Amifostine—Tachycardia—Docetaxel—breast cancer	8.7e-05	0.000756	CcSEcCtD
Amifostine—Feeling abnormal—Paclitaxel—breast cancer	8.67e-05	0.000753	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	8.65e-05	0.000751	CcSEcCtD
Amifostine—Bradycardia—Epirubicin—breast cancer	8.62e-05	0.000748	CcSEcCtD
Amifostine—Renal failure—Doxorubicin—breast cancer	8.58e-05	0.000745	CcSEcCtD
Amifostine—Erythema multiforme—Methotrexate—breast cancer	8.55e-05	0.000743	CcSEcCtD
Amifostine—Dizziness—Irinotecan—breast cancer	8.53e-05	0.000741	CcSEcCtD
Amifostine—ENPP1—Disease—HSPA1B—breast cancer	8.53e-05	0.000979	CbGpPWpGaD
Amifostine—Shock—Capecitabine—breast cancer	8.49e-05	0.000738	CcSEcCtD
Amifostine—Tachycardia—Capecitabine—breast cancer	8.43e-05	0.000732	CcSEcCtD
Amifostine—Urticaria—Paclitaxel—breast cancer	8.36e-05	0.000726	CcSEcCtD
Amifostine—Hypotension—Docetaxel—breast cancer	8.33e-05	0.000724	CcSEcCtD
Amifostine—Body temperature increased—Paclitaxel—breast cancer	8.32e-05	0.000722	CcSEcCtD
Amifostine—ENPP1—Metabolism—DPYD—breast cancer	8.26e-05	0.000948	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—MED12—breast cancer	8.26e-05	0.000948	CbGpPWpGaD
Amifostine—Vomiting—Mitoxantrone—breast cancer	8.2e-05	0.000712	CcSEcCtD
Amifostine—Vomiting—Irinotecan—breast cancer	8.2e-05	0.000712	CcSEcCtD
Amifostine—ENPP1—Disease—ENO1—breast cancer	8.17e-05	0.000938	CbGpPWpGaD
Amifostine—Dizziness—Fluorouracil—breast cancer	8.17e-05	0.00071	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—AKT1—breast cancer	8.17e-05	0.000938	CbGpPWpGaD
Amifostine—Rash—Mitoxantrone—breast cancer	8.13e-05	0.000706	CcSEcCtD
Amifostine—Rash—Irinotecan—breast cancer	8.13e-05	0.000706	CcSEcCtD
Amifostine—ENPP1—Metabolism—ALDOA—breast cancer	8.13e-05	0.000933	CbGpPWpGaD
Amifostine—Dermatitis—Irinotecan—breast cancer	8.13e-05	0.000706	CcSEcCtD
Amifostine—Dermatitis—Mitoxantrone—breast cancer	8.13e-05	0.000706	CcSEcCtD
Amifostine—Chills—Methotrexate—breast cancer	8.12e-05	0.000705	CcSEcCtD
Amifostine—Hypotension—Capecitabine—breast cancer	8.07e-05	0.000701	CcSEcCtD
Amifostine—Erythema multiforme—Epirubicin—breast cancer	8e-05	0.000695	CcSEcCtD
Amifostine—Vomiting—Gemcitabine—breast cancer	7.99e-05	0.000694	CcSEcCtD
Amifostine—Bradycardia—Doxorubicin—breast cancer	7.97e-05	0.000693	CcSEcCtD
Amifostine—Dyspnoea—Docetaxel—breast cancer	7.95e-05	0.00069	CcSEcCtD
Amifostine—Somnolence—Docetaxel—breast cancer	7.93e-05	0.000688	CcSEcCtD
Amifostine—Rash—Gemcitabine—breast cancer	7.92e-05	0.000688	CcSEcCtD
Amifostine—Dermatitis—Gemcitabine—breast cancer	7.91e-05	0.000687	CcSEcCtD
Amifostine—ENPP1—Metabolism—NCOA3—breast cancer	7.89e-05	0.000906	CbGpPWpGaD
Amifostine—Flushing—Epirubicin—breast cancer	7.86e-05	0.000682	CcSEcCtD
Amifostine—Vomiting—Fluorouracil—breast cancer	7.85e-05	0.000682	CcSEcCtD
Amifostine—ENPP1—Metabolism—SLC2A2—breast cancer	7.84e-05	0.0009	CbGpPWpGaD
Amifostine—Rash—Fluorouracil—breast cancer	7.79e-05	0.000677	CcSEcCtD
Amifostine—Dermatitis—Fluorouracil—breast cancer	7.78e-05	0.000676	CcSEcCtD
Amifostine—Hypersensitivity—Paclitaxel—breast cancer	7.75e-05	0.000673	CcSEcCtD
Amifostine—ENPP1—Disease—FGF3—breast cancer	7.73e-05	0.000887	CbGpPWpGaD
Amifostine—Dyspnoea—Capecitabine—breast cancer	7.7e-05	0.000668	CcSEcCtD
Amifostine—ENPP1—Metabolism—MTR—breast cancer	7.68e-05	0.000882	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ABCG2—breast cancer	7.68e-05	0.000882	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CPT1A—breast cancer	7.68e-05	0.000882	CbGpPWpGaD
Amifostine—Nausea—Mitoxantrone—breast cancer	7.66e-05	0.000665	CcSEcCtD
Amifostine—Nausea—Irinotecan—breast cancer	7.66e-05	0.000665	CcSEcCtD
Amifostine—ENPP1—Disease—JAG1—breast cancer	7.63e-05	0.000876	CbGpPWpGaD
Amifostine—ENPP1—Disease—FASN—breast cancer	7.63e-05	0.000876	CbGpPWpGaD
Amifostine—ENPP1—Disease—PARP1—breast cancer	7.6e-05	0.000872	CbGpPWpGaD
Amifostine—Chills—Epirubicin—breast cancer	7.6e-05	0.00066	CcSEcCtD
Amifostine—Arrhythmia—Epirubicin—breast cancer	7.56e-05	0.000657	CcSEcCtD
Amifostine—ENPP1—Metabolism—HPGDS—breast cancer	7.53e-05	0.000865	CbGpPWpGaD
Amifostine—ENPP1—Disease—CALCA—breast cancer	7.51e-05	0.000862	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HBA1—breast cancer	7.48e-05	0.000859	CbGpPWpGaD
Amifostine—Nausea—Gemcitabine—breast cancer	7.46e-05	0.000648	CcSEcCtD
Amifostine—Pruritus—Paclitaxel—breast cancer	7.44e-05	0.000646	CcSEcCtD
Amifostine—ENPP1—Disease—RPS6—breast cancer	7.42e-05	0.000851	CbGpPWpGaD
Amifostine—Erythema multiforme—Doxorubicin—breast cancer	7.41e-05	0.000643	CcSEcCtD
Amifostine—ENPP1—Disease—FGF4—breast cancer	7.36e-05	0.000845	CbGpPWpGaD
Amifostine—Feeling abnormal—Docetaxel—breast cancer	7.35e-05	0.000638	CcSEcCtD
Amifostine—Nausea—Fluorouracil—breast cancer	7.34e-05	0.000637	CcSEcCtD
Amifostine—ENPP1—Disease—CXCR4—breast cancer	7.33e-05	0.000842	CbGpPWpGaD
Amifostine—Ill-defined disorder—Methotrexate—breast cancer	7.31e-05	0.000635	CcSEcCtD
Amifostine—ENPP1—Metabolism—GSTT1—breast cancer	7.3e-05	0.000839	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ACHE—breast cancer	7.3e-05	0.000839	CbGpPWpGaD
Amifostine—Flushing—Doxorubicin—breast cancer	7.27e-05	0.000631	CcSEcCtD
Amifostine—ENPP1—Disease—SLC2A1—breast cancer	7.25e-05	0.000832	CbGpPWpGaD
Amifostine—Feeling abnormal—Capecitabine—breast cancer	7.11e-05	0.000618	CcSEcCtD
Amifostine—Malaise—Methotrexate—breast cancer	7.1e-05	0.000617	CcSEcCtD
Amifostine—ENPP1—Disease—TCF7L2—breast cancer	7.07e-05	0.000811	CbGpPWpGaD
Amifostine—Body temperature increased—Docetaxel—breast cancer	7.05e-05	0.000612	CcSEcCtD
Amifostine—Chills—Doxorubicin—breast cancer	7.03e-05	0.00061	CcSEcCtD
Amifostine—Arrhythmia—Doxorubicin—breast cancer	7e-05	0.000608	CcSEcCtD
Amifostine—Dizziness—Paclitaxel—breast cancer	6.96e-05	0.000604	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP17A1—breast cancer	6.91e-05	0.000794	CbGpPWpGaD
Amifostine—Urticaria—Capecitabine—breast cancer	6.86e-05	0.000596	CcSEcCtD
Amifostine—ENPP1—Metabolism—ENO1—breast cancer	6.85e-05	0.000786	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTGS1—breast cancer	6.85e-05	0.000786	CbGpPWpGaD
Amifostine—Ill-defined disorder—Epirubicin—breast cancer	6.84e-05	0.000594	CcSEcCtD
Amifostine—Body temperature increased—Capecitabine—breast cancer	6.82e-05	0.000593	CcSEcCtD
Amifostine—Convulsion—Methotrexate—breast cancer	6.82e-05	0.000593	CcSEcCtD
Amifostine—ENPP1—Disease—HSP90AA1—breast cancer	6.82e-05	0.000782	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP2D6—breast cancer	6.71e-05	0.000771	CbGpPWpGaD
Amifostine—Chest pain—Methotrexate—breast cancer	6.7e-05	0.000582	CcSEcCtD
Amifostine—Vomiting—Paclitaxel—breast cancer	6.69e-05	0.000581	CcSEcCtD
Amifostine—Malaise—Epirubicin—breast cancer	6.65e-05	0.000577	CcSEcCtD
Amifostine—Rash—Paclitaxel—breast cancer	6.63e-05	0.000576	CcSEcCtD
Amifostine—ENPP1—Disease—PRL—breast cancer	6.63e-05	0.000761	CbGpPWpGaD
Amifostine—Dermatitis—Paclitaxel—breast cancer	6.63e-05	0.000576	CcSEcCtD
Amifostine—Discomfort—Methotrexate—breast cancer	6.62e-05	0.000575	CcSEcCtD
Amifostine—Syncope—Epirubicin—breast cancer	6.61e-05	0.000574	CcSEcCtD
Amifostine—ENPP1—Metabolism—NCOA2—breast cancer	6.59e-05	0.000756	CbGpPWpGaD
Amifostine—Hypersensitivity—Docetaxel—breast cancer	6.57e-05	0.000571	CcSEcCtD
Amifostine—ENPP1—Disease—ADAM10—breast cancer	6.53e-05	0.00075	CbGpPWpGaD
Amifostine—Loss of consciousness—Epirubicin—breast cancer	6.48e-05	0.000563	CcSEcCtD
Amifostine—Anaphylactic shock—Methotrexate—breast cancer	6.43e-05	0.000558	CcSEcCtD
Amifostine—ENPP1—Metabolism—FASN—breast cancer	6.39e-05	0.000734	CbGpPWpGaD
Amifostine—Convulsion—Epirubicin—breast cancer	6.38e-05	0.000555	CcSEcCtD
Amifostine—ENPP1—Metabolism—BCHE—breast cancer	6.36e-05	0.00073	CbGpPWpGaD
Amifostine—Hypertension—Epirubicin—breast cancer	6.36e-05	0.000553	CcSEcCtD
Amifostine—Hypersensitivity—Capecitabine—breast cancer	6.36e-05	0.000552	CcSEcCtD
Amifostine—ENPP1—Disease—FGF10—breast cancer	6.36e-05	0.00073	CbGpPWpGaD
Amifostine—Ill-defined disorder—Doxorubicin—breast cancer	6.33e-05	0.000549	CcSEcCtD
Amifostine—Pruritus—Docetaxel—breast cancer	6.31e-05	0.000548	CcSEcCtD
Amifostine—ENPP1—Metabolism—SLC5A5—breast cancer	6.29e-05	0.000722	CbGpPWpGaD
Amifostine—Chest pain—Epirubicin—breast cancer	6.27e-05	0.000545	CcSEcCtD
Amifostine—Nausea—Paclitaxel—breast cancer	6.25e-05	0.000543	CcSEcCtD
Amifostine—Discomfort—Epirubicin—breast cancer	6.2e-05	0.000538	CcSEcCtD
Amifostine—Malaise—Doxorubicin—breast cancer	6.15e-05	0.000534	CcSEcCtD
Amifostine—ENPP1—Disease—PDGFA—breast cancer	6.13e-05	0.000704	CbGpPWpGaD
Amifostine—Syncope—Doxorubicin—breast cancer	6.11e-05	0.000531	CcSEcCtD
Amifostine—Pruritus—Capecitabine—breast cancer	6.11e-05	0.00053	CcSEcCtD
Amifostine—ENPP1—Metabolism—SLC2A1—breast cancer	6.07e-05	0.000697	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NQO1—breast cancer	6.07e-05	0.000697	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFBR2—breast cancer	6.05e-05	0.000694	CbGpPWpGaD
Amifostine—Anaphylactic shock—Epirubicin—breast cancer	6.01e-05	0.000522	CcSEcCtD
Amifostine—Hypotension—Methotrexate—breast cancer	6.01e-05	0.000522	CcSEcCtD
Amifostine—Loss of consciousness—Doxorubicin—breast cancer	5.99e-05	0.000521	CcSEcCtD
Amifostine—ENPP1—Disease—ITPR1—breast cancer	5.95e-05	0.000683	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP3A4—breast cancer	5.92e-05	0.00068	CbGpPWpGaD
Amifostine—Shock—Epirubicin—breast cancer	5.92e-05	0.000514	CcSEcCtD
Amifostine—ENPP1—Disease—STAT5A—breast cancer	5.91e-05	0.000678	CbGpPWpGaD
Amifostine—ENPP1—Disease—ERBB4—breast cancer	5.91e-05	0.000678	CbGpPWpGaD
Amifostine—Convulsion—Doxorubicin—breast cancer	5.91e-05	0.000513	CcSEcCtD
Amifostine—Dizziness—Docetaxel—breast cancer	5.9e-05	0.000512	CcSEcCtD
Amifostine—Hypertension—Doxorubicin—breast cancer	5.89e-05	0.000511	CcSEcCtD
Amifostine—Tachycardia—Epirubicin—breast cancer	5.87e-05	0.00051	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP1B1—breast cancer	5.82e-05	0.000668	CbGpPWpGaD
Amifostine—Chest pain—Doxorubicin—breast cancer	5.8e-05	0.000504	CcSEcCtD
Amifostine—Discomfort—Doxorubicin—breast cancer	5.74e-05	0.000498	CcSEcCtD
Amifostine—Dyspnoea—Methotrexate—breast cancer	5.73e-05	0.000498	CcSEcCtD
Amifostine—ENPP1—Disease—SMAD4—breast cancer	5.72e-05	0.000657	CbGpPWpGaD
Amifostine—Somnolence—Methotrexate—breast cancer	5.71e-05	0.000496	CcSEcCtD
Amifostine—Dizziness—Capecitabine—breast cancer	5.71e-05	0.000496	CcSEcCtD
Amifostine—ENPP1—Metabolism—HSP90AA1—breast cancer	5.71e-05	0.000655	CbGpPWpGaD
Amifostine—Vomiting—Docetaxel—breast cancer	5.67e-05	0.000492	CcSEcCtD
Amifostine—Rash—Docetaxel—breast cancer	5.62e-05	0.000488	CcSEcCtD
Amifostine—Hypotension—Epirubicin—breast cancer	5.62e-05	0.000488	CcSEcCtD
Amifostine—Dermatitis—Docetaxel—breast cancer	5.62e-05	0.000488	CcSEcCtD
Amifostine—ENPP1—Disease—HES1—breast cancer	5.59e-05	0.000641	CbGpPWpGaD
Amifostine—Anaphylactic shock—Doxorubicin—breast cancer	5.56e-05	0.000483	CcSEcCtD
Amifostine—ENPP1—Disease—NCOR1—breast cancer	5.56e-05	0.000638	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NCOA1—breast cancer	5.55e-05	0.000637	CbGpPWpGaD
Amifostine—ENPP1—Disease—FGF1—breast cancer	5.49e-05	0.000631	CbGpPWpGaD
Amifostine—Vomiting—Capecitabine—breast cancer	5.49e-05	0.000477	CcSEcCtD
Amifostine—Shock—Doxorubicin—breast cancer	5.47e-05	0.000476	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP19A1—breast cancer	5.47e-05	0.000628	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—STK11—breast cancer	5.47e-05	0.000628	CbGpPWpGaD
Amifostine—ENPP1—Disease—NRG1—breast cancer	5.45e-05	0.000626	CbGpPWpGaD
Amifostine—Rash—Capecitabine—breast cancer	5.44e-05	0.000473	CcSEcCtD
Amifostine—Dermatitis—Capecitabine—breast cancer	5.44e-05	0.000472	CcSEcCtD
Amifostine—Tachycardia—Doxorubicin—breast cancer	5.43e-05	0.000472	CcSEcCtD
Amifostine—ENPP1—Disease—H2AFX—breast cancer	5.41e-05	0.000622	CbGpPWpGaD
Amifostine—Dyspnoea—Epirubicin—breast cancer	5.36e-05	0.000466	CcSEcCtD
Amifostine—Somnolence—Epirubicin—breast cancer	5.35e-05	0.000464	CcSEcCtD
Amifostine—Nausea—Docetaxel—breast cancer	5.3e-05	0.00046	CcSEcCtD
Amifostine—Feeling abnormal—Methotrexate—breast cancer	5.3e-05	0.00046	CcSEcCtD
Amifostine—ENPP1—Disease—ERCC2—breast cancer	5.22e-05	0.0006	CbGpPWpGaD
Amifostine—Hypotension—Doxorubicin—breast cancer	5.2e-05	0.000452	CcSEcCtD
Amifostine—Nausea—Capecitabine—breast cancer	5.13e-05	0.000445	CcSEcCtD
Amifostine—ENPP1—Disease—ERBB3—breast cancer	5.11e-05	0.000586	CbGpPWpGaD
Amifostine—Urticaria—Methotrexate—breast cancer	5.11e-05	0.000443	CcSEcCtD
Amifostine—ENPP1—Disease—FGFR2—breast cancer	5.1e-05	0.000586	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—COMT—breast cancer	5.09e-05	0.000584	CbGpPWpGaD
Amifostine—Body temperature increased—Methotrexate—breast cancer	5.08e-05	0.000441	CcSEcCtD
Amifostine—ENPP1—Metabolism—GSTP1—breast cancer	5.06e-05	0.000581	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HMOX1—breast cancer	4.99e-05	0.000573	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ITPR1—breast cancer	4.98e-05	0.000572	CbGpPWpGaD
Amifostine—Dyspnoea—Doxorubicin—breast cancer	4.96e-05	0.000431	CcSEcCtD
Amifostine—Feeling abnormal—Epirubicin—breast cancer	4.96e-05	0.00043	CcSEcCtD
Amifostine—Somnolence—Doxorubicin—breast cancer	4.95e-05	0.00043	CcSEcCtD
Amifostine—ENPP1—Disease—MTHFR—breast cancer	4.91e-05	0.000564	CbGpPWpGaD
Amifostine—ENPP1—Disease—TERT—breast cancer	4.9e-05	0.000562	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ABCB1—breast cancer	4.79e-05	0.00055	CbGpPWpGaD
Amifostine—Urticaria—Epirubicin—breast cancer	4.78e-05	0.000415	CcSEcCtD
Amifostine—ENPP1—Disease—FGFR1—breast cancer	4.75e-05	0.000546	CbGpPWpGaD
Amifostine—Body temperature increased—Epirubicin—breast cancer	4.75e-05	0.000413	CcSEcCtD
Amifostine—Hypersensitivity—Methotrexate—breast cancer	4.73e-05	0.000411	CcSEcCtD
Amifostine—ENPP1—Metabolism—TYMS—breast cancer	4.71e-05	0.00054	CbGpPWpGaD
Amifostine—ENPP1—Disease—HIF1A—breast cancer	4.68e-05	0.000538	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PLA2G4A—breast cancer	4.65e-05	0.000534	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTM1—breast cancer	4.65e-05	0.000534	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NCOR1—breast cancer	4.65e-05	0.000534	CbGpPWpGaD
Amifostine—Feeling abnormal—Doxorubicin—breast cancer	4.59e-05	0.000398	CcSEcCtD
Amifostine—Pruritus—Methotrexate—breast cancer	4.55e-05	0.000395	CcSEcCtD
Amifostine—ENPP1—Disease—CAV1—breast cancer	4.53e-05	0.00052	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GPX1—breast cancer	4.46e-05	0.000511	CbGpPWpGaD
Amifostine—Hypersensitivity—Epirubicin—breast cancer	4.43e-05	0.000385	CcSEcCtD
Amifostine—Urticaria—Doxorubicin—breast cancer	4.42e-05	0.000384	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP1A1—breast cancer	4.41e-05	0.000506	CbGpPWpGaD
Amifostine—Body temperature increased—Doxorubicin—breast cancer	4.4e-05	0.000382	CcSEcCtD
Amifostine—ENPP1—Metabolism—ERCC2—breast cancer	4.37e-05	0.000502	CbGpPWpGaD
Amifostine—ENPP1—Disease—NOS2—breast cancer	4.26e-05	0.000489	CbGpPWpGaD
Amifostine—Pruritus—Epirubicin—breast cancer	4.25e-05	0.00037	CcSEcCtD
Amifostine—Dizziness—Methotrexate—breast cancer	4.25e-05	0.000369	CcSEcCtD
Amifostine—ENPP1—Disease—NOTCH1—breast cancer	4.22e-05	0.000484	CbGpPWpGaD
Amifostine—ENPP1—Disease—APC—breast cancer	4.13e-05	0.000474	CbGpPWpGaD
Amifostine—ENPP1—Disease—KIT—breast cancer	4.13e-05	0.000474	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—MTHFR—breast cancer	4.11e-05	0.000472	CbGpPWpGaD
Amifostine—Hypersensitivity—Doxorubicin—breast cancer	4.1e-05	0.000356	CcSEcCtD
Amifostine—Vomiting—Methotrexate—breast cancer	4.09e-05	0.000355	CcSEcCtD
Amifostine—ENPP1—Disease—EGF—breast cancer	4.08e-05	0.000468	CbGpPWpGaD
Amifostine—Rash—Methotrexate—breast cancer	4.05e-05	0.000352	CcSEcCtD
Amifostine—Dermatitis—Methotrexate—breast cancer	4.05e-05	0.000352	CcSEcCtD
Amifostine—Dizziness—Epirubicin—breast cancer	3.98e-05	0.000345	CcSEcCtD
Amifostine—Pruritus—Doxorubicin—breast cancer	3.94e-05	0.000342	CcSEcCtD
Amifostine—ENPP1—Disease—BRAF—breast cancer	3.88e-05	0.000445	CbGpPWpGaD
Amifostine—Vomiting—Epirubicin—breast cancer	3.82e-05	0.000332	CcSEcCtD
Amifostine—Nausea—Methotrexate—breast cancer	3.82e-05	0.000332	CcSEcCtD
Amifostine—ENPP1—Metabolism—CAV1—breast cancer	3.79e-05	0.000435	CbGpPWpGaD
Amifostine—Rash—Epirubicin—breast cancer	3.79e-05	0.000329	CcSEcCtD
Amifostine—Dermatitis—Epirubicin—breast cancer	3.79e-05	0.000329	CcSEcCtD
Amifostine—ENPP1—Disease—AKT2—breast cancer	3.77e-05	0.000433	CbGpPWpGaD
Amifostine—Dizziness—Doxorubicin—breast cancer	3.68e-05	0.00032	CcSEcCtD
Amifostine—ENPP1—Disease—PIK3CD—breast cancer	3.63e-05	0.000416	CbGpPWpGaD
Amifostine—ENPP1—Disease—SERPINE1—breast cancer	3.59e-05	0.000412	CbGpPWpGaD
Amifostine—Nausea—Epirubicin—breast cancer	3.57e-05	0.00031	CcSEcCtD
Amifostine—Vomiting—Doxorubicin—breast cancer	3.54e-05	0.000307	CcSEcCtD
Amifostine—Rash—Doxorubicin—breast cancer	3.51e-05	0.000305	CcSEcCtD
Amifostine—Dermatitis—Doxorubicin—breast cancer	3.51e-05	0.000304	CcSEcCtD
Amifostine—ENPP1—Metabolism—PIK3CG—breast cancer	3.46e-05	0.000397	CbGpPWpGaD
Amifostine—ENPP1—Disease—NOS3—breast cancer	3.42e-05	0.000393	CbGpPWpGaD
Amifostine—Nausea—Doxorubicin—breast cancer	3.31e-05	0.000287	CcSEcCtD
Amifostine—ENPP1—Disease—MDM2—breast cancer	3.25e-05	0.000373	CbGpPWpGaD
Amifostine—ENPP1—Disease—RAF1—breast cancer	3.24e-05	0.000372	CbGpPWpGaD
Amifostine—ENPP1—Disease—ERBB2—breast cancer	3.2e-05	0.000368	CbGpPWpGaD
Amifostine—ENPP1—Disease—MTOR—breast cancer	3.16e-05	0.000363	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CB—breast cancer	3.16e-05	0.000363	CbGpPWpGaD
Amifostine—ENPP1—Disease—CD4—breast cancer	3.16e-05	0.000362	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTGS2—breast cancer	3.13e-05	0.00036	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CD—breast cancer	3.04e-05	0.000349	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ALB—breast cancer	3e-05	0.000344	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN1B—breast cancer	2.97e-05	0.000341	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NOS3—breast cancer	2.87e-05	0.000329	CbGpPWpGaD
Amifostine—ENPP1—Disease—CTNNB1—breast cancer	2.8e-05	0.000322	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN1A—breast cancer	2.74e-05	0.000314	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTEN—breast cancer	2.73e-05	0.000314	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CB—breast cancer	2.65e-05	0.000304	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTGS2—breast cancer	2.62e-05	0.000301	CbGpPWpGaD
Amifostine—ENPP1—Disease—SRC—breast cancer	2.53e-05	0.000291	CbGpPWpGaD
Amifostine—ENPP1—Disease—STAT3—breast cancer	2.44e-05	0.00028	CbGpPWpGaD
Amifostine—ENPP1—Disease—MAPK3—breast cancer	2.33e-05	0.000268	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTEN—breast cancer	2.29e-05	0.000263	CbGpPWpGaD
Amifostine—ENPP1—Disease—MYC—breast cancer	2.27e-05	0.000261	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFB1—breast cancer	2.26e-05	0.00026	CbGpPWpGaD
Amifostine—ENPP1—Disease—EGFR—breast cancer	2.22e-05	0.000255	CbGpPWpGaD
Amifostine—ENPP1—Disease—KRAS—breast cancer	2.1e-05	0.000241	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CA—breast cancer	1.93e-05	0.000221	CbGpPWpGaD
Amifostine—ENPP1—Disease—HRAS—breast cancer	1.78e-05	0.000205	CbGpPWpGaD
Amifostine—ENPP1—Disease—IL6—breast cancer	1.71e-05	0.000196	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CA—breast cancer	1.61e-05	0.000185	CbGpPWpGaD
Amifostine—ENPP1—Disease—AKT1—breast cancer	1.57e-05	0.000181	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AKT1—breast cancer	1.32e-05	0.000151	CbGpPWpGaD
